Suppr超能文献

NADPH氧化酶-4作为人视网膜母细胞瘤中活性氧应激指标的预后意义

Prognostic significance of NADPH oxidase-4 as an indicator of reactive oxygen species stress in human retinoblastoma.

作者信息

Singh Lata, Saini Neeru, Pushker Neelam, Sen Seema, Sharma Anjana, Kashyap Seema

机构信息

Department of Ocular Pathology, Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Functional Genomics Unit, Institute of Genomics and Integrative Biology, Mall Road, New Delhi, India.

出版信息

Int J Clin Oncol. 2016 Aug;21(4):651-657. doi: 10.1007/s10147-016-0951-7. Epub 2016 Feb 8.

Abstract

BACKGROUND

Reactive oxygen species (ROS) have been shown to enhance the proliferation of cancer cells. NADPH oxidases (NOX4) are a major intracellular source of ROS and are found to be associated with cancer and tumor cell invasion. Therefore, the purpose of this study is to evaluate the expression of NOX4 protein in human retinoblastoma.

METHODS

Immunohistochemical expression of NOX4 protein was analyzed in 109 specimens from prospective cases of retinoblastoma and then correlated with clinicopathological parameters and patient survival. Western blotting confirmed and validated the immunoreactivity of NOX4 protein.

RESULTS

In our study we found a male preponderance (55.9 %), and 25/109 (22.9 %) were bilateral. Massive choroidal invasion was the histopathological high-risk factor (HRF) most frequently observed, in 42.2 % of the cases. NOX4 protein was expressed in 67.88 % (74/109) of primary retinoblastoma cases and was confirmed by Western blotting. NOX4 was statistically significant with massive choroidal invasion and pathological TNM staging. There was a statistically significant difference in overall survival in patients with NOX4 expression (p = 0.0461).

CONCLUSION

This is the first study to show the expression of NOX4 protein in retinoblastoma tumors. Hence, a retinoblastoma tumor may exhibit greater ROS stress. This protein may prove to be useful as a future therapeutic target for improving the management of retinoblastoma.

摘要

背景

活性氧(ROS)已被证明可促进癌细胞增殖。烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NOX4)是ROS的主要细胞内来源,且被发现与癌症及肿瘤细胞侵袭相关。因此,本研究旨在评估NOX4蛋白在人类视网膜母细胞瘤中的表达情况。

方法

对109例视网膜母细胞瘤前瞻性病例的标本进行NOX4蛋白的免疫组化表达分析,然后将其与临床病理参数及患者生存率进行关联分析。蛋白质印迹法证实并验证了NOX4蛋白的免疫反应性。

结果

在我们的研究中,我们发现男性占优势(55.9%),且109例中有25例(22.9%)为双侧病变。脉络膜广泛浸润是最常观察到的组织病理学高危因素(HRF),在42.2%的病例中出现。NOX4蛋白在67.88%(74/109)的原发性视网膜母细胞瘤病例中表达,并通过蛋白质印迹法得到证实。NOX4与脉络膜广泛浸润及病理TNM分期具有统计学意义。NOX4表达患者的总生存率存在统计学显著差异(p = 0.0461)。

结论

这是第一项显示NOX4蛋白在视网膜母细胞瘤肿瘤中表达的研究。因此,视网膜母细胞瘤肿瘤可能表现出更大的ROS应激。这种蛋白可能被证明是未来改善视网膜母细胞瘤治疗管理的有用治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验